AIMC Journal:
Vascular pharmacology

Showing 1 to 2 of 2 articles

Integrated multi-omics and experimental validation reveal CSK and FBLN1 as key targets of stanozolol in accelerating atherosclerosis.

Vascular pharmacology
BACKGROUND: Stanozolol, a synthetic anabolic androgenic steroid (AAS) widely abused to enhance performance, has poorly defined toxicological mechanisms in atherosclerosis (AS). METHODS: An AS model was established in ApoE-/- mice, followed by a 12-we...

Cardiac magnetic resonance in patients with acute myocardial infarction: The added clinical value.

Vascular pharmacology
Cardiovascular magnetic resonance (CMR) has emerged as the reference noninvasive modality for a comprehensive assessment of myocardial injury following acute myocardial infarction (AMI). Beyond accurate quantification of ventricular volumes and eject...